These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23176143)

  • 1. Doxorubicin-enriched, ALDH(br) mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1.
    Zhuang X; Zhang W; Chen Y; Han X; Li J; Zhang Y; Zhang Y; Zhang S; Liu B
    BMC Cancer; 2012 Nov; 12():549. PubMed ID: 23176143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The therapeutic effect of HSV1-hGM-CSF combined with doxorubicin on the mouse breast cancer model].
    Zhuang XF; Zhang SR; Liu BL; Wu JL; Li XQ; Gu HG; Shu Y
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):178-185. PubMed ID: 29575835
    [No Abstract]   [Full Text] [Related]  

  • 3. Ovarian cancer stem cells are enriched in side population and aldehyde dehydrogenase bright overlapping population.
    Yasuda K; Torigoe T; Morita R; Kuroda T; Takahashi A; Matsuzaki J; Kochin V; Asanuma H; Hasegawa T; Saito T; Hirohashi Y; Sato N
    PLoS One; 2013; 8(8):e68187. PubMed ID: 23967051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice.
    Thomas ED; Meza-Perez S; Bevis KS; Randall TD; Gillespie GY; Langford C; Alvarez RD
    J Ovarian Res; 2016 Oct; 9(1):70. PubMed ID: 27784340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel oncolytic herpes simplex virus type 2 has potent anti-tumor activity.
    Zhao Q; Zhang W; Ning Z; Zhuang X; Lu H; Liang J; Li J; Zhang Y; Dong Y; Zhang Y; Zhang S; Liu S; Liu B
    PLoS One; 2014; 9(3):e93103. PubMed ID: 24671154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2α.
    Kim RJ; Park JR; Roh KJ; Choi AR; Kim SR; Kim PH; Yu JH; Lee JW; Ahn SH; Gong G; Hwang JW; Kang KS; Kong G; Sheen YY; Nam JS
    Cancer Lett; 2013 Jun; 333(1):18-31. PubMed ID: 23174107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic CD8+ T cell-mediated tumoricidal effects by intratumoral treatment of oncolytic herpes simplex virus with the agonistic monoclonal antibody for murine glucocorticoid-induced tumor necrosis factor receptor.
    Ishihara M; Seo N; Mitsui J; Muraoka D; Tanaka M; Mineno J; Ikeda H; Shiku H
    PLoS One; 2014; 9(8):e104669. PubMed ID: 25105508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of breast cancer stem cells with oncolytic herpes simplex virus.
    Li J; Zeng W; Huang Y; Zhang Q; Hu P; Rabkin SD; Liu R
    Cancer Gene Ther; 2012 Oct; 19(10):707-14. PubMed ID: 22898897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining oncolytic HSV-1 with immunogenic cell death-inducing drug mitoxantrone breaks cancer immune tolerance and improves therapeutic efficacy.
    Workenhe ST; Pol JG; Lichty BD; Cummings DT; Mossman KL
    Cancer Immunol Res; 2013 Nov; 1(5):309-19. PubMed ID: 24777969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ALDH1⁺ subpopulation of the human NMFH-1 cell line exhibits cancer stem-like characteristics.
    Li D; Zhang T; Gu W; Li P; Cheng X; Tong T; Wang W
    Oncol Rep; 2015 May; 33(5):2291-8. PubMed ID: 25760144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldehyde dehydrogenase-1 is a specific marker for stem cells in human lung adenocarcinoma.
    Liang D; Shi Y
    Med Oncol; 2012 Jun; 29(2):633-9. PubMed ID: 21484084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic herpes simplex virus treatment of metastatic breast cancer.
    Wang J; Hu P; Zeng M; Rabkin SD; Liu R
    Int J Oncol; 2012 Mar; 40(3):757-63. PubMed ID: 22108767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic herpes simplex virus 1 encoding 15-prostaglandin dehydrogenase mitigates immune suppression and reduces ectopic primary and metastatic breast cancer in mice.
    Walker JD; Sehgal I; Kousoulas KG
    J Virol; 2011 Jul; 85(14):7363-71. PubMed ID: 21543507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic reovirus effectively targets breast cancer stem cells.
    Marcato P; Dean CA; Giacomantonio CA; Lee PW
    Mol Ther; 2009 Jun; 17(6):972-9. PubMed ID: 19293772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity.
    Wang L; Park P; Zhang H; La Marca F; Lin CY
    Int J Cancer; 2011 Jan; 128(2):294-303. PubMed ID: 20309879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oncolytic herpes simplex virus vector G47∆ effectively targets breast cancer stem cells.
    Zeng W; Hu P; Wu J; Wang J; Li J; Lei L; Liu R
    Oncol Rep; 2013 Mar; 29(3):1108-14. PubMed ID: 23292314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells.
    Wang H; Chen NG; Minev BR; Szalay AA
    J Transl Med; 2012 Aug; 10():167. PubMed ID: 22901246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
    Wang L; Park P; La Marca F; Than KD; Lin CY
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.
    Visus C; Wang Y; Lozano-Leon A; Ferris RL; Silver S; Szczepanski MJ; Brand RE; Ferrone CR; Whiteside TL; Ferrone S; DeLeo AB; Wang X
    Clin Cancer Res; 2011 Oct; 17(19):6174-84. PubMed ID: 21856769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases.
    Chen X; Han J; Chu J; Zhang L; Zhang J; Chen C; Chen L; Wang Y; Wang H; Yi L; Elder JB; Wang QE; He X; Kaur B; Chiocca EA; Yu J
    Oncotarget; 2016 May; 7(19):27764-77. PubMed ID: 27050072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.